Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?
09:05am, Monday, 23'rd Dec 2024
TECH enters a co-marketing and co-promotion agreement with Waters Corporation to expand the reach of advanced biotherapeutic characterization and development processes.
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
07:00am, Friday, 20'th Dec 2024
MINNEAPOLIS , Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morga
YSX TECH. CO., LTD Announces Closing of Its Initial Public Offering and Full Exercise of Underwriter's Over-Allotment Option
12:10pm, Thursday, 19'th Dec 2024
Guangzhou, Dec. 19, 2024 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (the “Company” or “YSXT”), a Cayman Islands exempted company that, through its variable interest entities in China, provides com
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
07:00am, Thursday, 19'th Dec 2024
MINNEAPOLIS , Dec. 19, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co-promotion
ScaleReady awards a G-Rex® Grant to Moonlight Bio
07:00am, Wednesday, 18'th Dec 2024
ST. PAUL, Minn. , Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that Moonlight Bio has
YSX TECH. CO., LTD Announces Pricing of Its Initial Public Offering
05:18pm, Tuesday, 17'th Dec 2024
Guangzhou, Dec. 17, 2024 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (the “Company” or “YSXT”), a Cayman Islands exempted company that, through its variable interest entities in China, provides com
Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?
08:16am, Thursday, 12'th Dec 2024
TECH's Asuragen brand unveils a highly sensitive ESR1 mutation monitoring assay.
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
07:00am, Thursday, 12'th Dec 2024
MINNEAPOLIS , Dec. 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagno
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
07:00am, Tuesday, 10'th Dec 2024
Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium MINNEAPOLIS , Dec. 10, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a B
Should You Continue to Retain Bio-Techne Stock in Your Portfolio?
07:11am, Monday, 02'nd Dec 2024
Bio-Techne's success with four growth verticals and expansion through acquisitions bode well.
Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 29'th Nov 2024
Techne (TECH) reported earnings 30 days ago. What's next for the stock?
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
07:00am, Wednesday, 27'th Nov 2024
MINNEAPOLIS , Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Health
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne
09:02am, Monday, 25'th Nov 2024
WEST SACRAMENTO, Calif. , Nov. 25, 2024 /PRNewswire/ -- Gemini Bioproducts, LLC ("GeminiBio"), a leading supplier of cell culture reagents and process liquids, and a portfolio company of BelHealth Inv
OverT Bio Receives $120K G-Rex® Grant to Propel Solid Tumor Cell Therapy Advancements
09:00am, Friday, 22'nd Nov 2024
NEW YORK--(BUSINESS WIRE)--OverT Bio, an NYC-based cell therapy company, today announced that it has been awarded a $120,000 G-Rex Grant from ScaleReadyTM, in collaboration with Wilson Wolf Manufactur
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
07:00am, Wednesday, 20'th Nov 2024
MINNEAPOLIS , Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagno
